Abstract:Background: Urinary acetone is produced from fat metabolism in human body, which can be accelerated in diabetic patients because of insufficient utilization and storage of glucose. Therefore, it has the potential to be used for diagnosis of type 2 diabetes (T2D).Methods: We recruited 180 T2D patients and 180 healthy volunteers from three hospitals for a multi-center study. Urine samples were collected in the morning when donators were fasting and stored in glass bottles. Acetone in the headspace of these bottles was qualitatively and quantitatively detected by a proton transfer reaction mass spectrometry (PTR-MS) instrument in eight hours. The detection time was less than one minute. Diagnostic model was established using urinary acetone data from one hospital and validated in another two hospitals. Findings: Using a threshold of 644.1 ppb, a diagnostic model was established using urinary acetone with an accuracy of 81.3% (sensitivity: 73.3%, specificity: 89.3%) in hospital Ⅰ. In the verification studies, the accuracies were 92.5% (sensitivity: 88.7%, specificity: 96.2%) in hospital Ⅱ and 83.7% (sensitivity: 76.9%, specificity: 90.4%) in hospital Ⅲ, respectively. The sensitivity for 35 newly diagnosed patients was 85.7%. The accuracy is comparable to that of clinically used diagnosis methods, fasting plasma glucose (FPG), oral glucose tolerance test (OGTT), and glycosylated hemoglobin (HbA1c) test. In addition, the urinary acetone had good linear relation to HbA1c but poor linear relation to FPG, two main T2D biomarkers in clinical tests.Interpretation: The newly developed technology is completely non-invasive and much more rapid than clinical FPG, OGTT, and HbA1c tests. It has the potential to become a novel T2D diagnosis method. But its applicability in different human races still need more validations.Funding: This research was funded by National Natural Science Foundation of China (22076190), Youth Innovation Promotion Association, CAS (2019432), Joint Fund between the Second Affiliated Hospital of Anhui Medical University and the Center of Medical Physics and Technology of Hefei Institute of Physical Sciences of Chinese Academy of Sciences (LHJJ2020006), and President Foundation of Hefei Institute of Physical Sciences of Chinese Academy of Sciences (YZJJ2022QN45, YZJJZX202009).Declaration of Interest: The authors declare that they have no conflict of interest.Ethical Approval: This study was approved by the ethics committee of the Second Hospital of Anhui Medical University.

Rethinking the Use of Urine Dipstick for Early Diagnosis of Type 2 Diabetes Mellitus.

Early Diagnosis of T2DM Using High Sensitive Tests in the Mandatory Medical Examinations for Fishers, Seafarers and Other Transport Workers

SS48-04 SCREENING FOR TYPE 2 DIABETES AND HYPERTENSION IN SEAFARERS' MEDICAL EXAMINATIONS

Saliva diagnostic utility in patients with type 2 diabetes: Future standard method

Non-Invasive and Rapid Diagnosis of Type 2 Diabetes Using Urinary Acetone: a Prospective Multi - Center Study

Time-based investigation of urinary metabolic markers for Type 2 diabetes: Metabolomics approach for diabetes management

Usefulness of urine dipstick test in the management of adverse events associated with immune checkpoint inhibitors

Metabolomic Investigation of Blood and Urinary Amino Acids and Derivatives in Patients with Type 2 Diabetes Mellitus and Early Diabetic Kidney Disease

Application of analytical performance specifications for urine test strip methods: Importance of reflectance signals

Biomarker Profiling with Targeted Metabolomic Analysis of Plasma and Urine Samples in Patients with Type 2 Diabetes Mellitus and Early Diabetic Kidney Disease

Rapid and non-invasive diagnosis of type 2 diabetes through sniffing urinary acetone by a proton transfer reaction mass spectrometry

Review on the screening of urine glucose for early diagnosis of type 2 diabetes mellitus in school children and adolescents with obesity in Hong Kong

Undiagnosed type 2 diabetes is common – intensified screening of established risk groups is imperative in Sweden: the SDPP cohort

Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus

Monitoring Diabetes Nephropathy by Urine Examination

Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients

The compliance and cost-effectiveness of smartphone urinalysis albumin screening for people with diabetes in England

Urine biomarkers in type 2 diabetes mellitus with or without microvascular complications

Diagnostic Strategy to Improve the Efficiency of Screening Diabetes--roc Analysis for Fasting Plasma Glucose.

HbA1C for Diagnosing Diabetes:Past,present,and Future

Urinary orosomucoid and retinol binding protein levels as early diagnostic markers for diabetic nephropathy